Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Vaccination and hygiene are key to preventing Feline Calicivirus in cats.

Injecting CHIR-99021 into goose embryos improves feather growth by changing gene activity and energy processes.

XEDAR deficiency prevents muscle degeneration in EDA-A2 transgenic mice.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Altering the keratin 17 gene in mice hair follicles caused temporary hair issues, but changes were minimal and short-lived.

MPA increases cancer spread by boosting Eph A2 activity.

Early involution in Hirosaki hairless rats' mammary glands is linked to a unique modification of STAT5A.

Mutant MK6a transgenes in mice cause blistering, hair loss, and potential human alopecia.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

The virus linked to a rare disease was found in a patient's blood and urine before skin symptoms appeared.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Eyelid cells share signaling components but differ in pathway activity.

Expressing the human vitamin D receptor in skin cells prevents hair loss in certain mice.

TNF alpha in skin cells causes weight loss, hair and fat issues, and skin inflammation in mice.

Activated β-catenin affects hair growth and skin thickness, and changes are reversible.

Activated erbB-2 in mice skin causes severe skin and hair abnormalities.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Infectious virus was not found after the third remdesivir dose, suggesting early end of isolation is possible.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Children may have lingering respiratory issues after recovering from COVID-19.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

A new microneedle patch effectively treats hair loss by delivering growth factors to the skin.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Better DNA uptake in the skin leads to stronger immune responses.

Five FDA-approved drugs may help block COVID-19 virus entry.